Scientific Committee
Scientific committee
Antoni Bayes-Genis
Institut del Cor - Hospital Universitari Germans Trias i Pujol,
Barcelona, Spain
Dr. Antoni Bayes-Genis is chair of the Germans Trias Heart Institute (iCor), Director of the Cardiology Department at Hospital Universitari Germans Trias i Pujol (Badalona, Spain), Director of the ICREC (Heart Failure and Cardiac Regeneration) Research Program and Full Professor at Autonomous University of Barcelona. He has published over 4000 SCI papers with more than 10.500 citations. He has contributed to over 600 national and international conferences in oral format. He is inventor of 9 international patents, Director/Co-director of 13 PhD Thesis and has established several collaboration agreements with biotechnological companies. His research is focussed in two main areas, one more clinical and another basic-translational. From the clinical stand-point he is interested in novel biomakers for diagnosis and prognosis in heart failure and sudden death as well as telemedicine. At the basic-translational level he is interested in mesenchymal stem cells (adipose tissue-derived, circulating progenitors and umbilical cord-derived) and cardiac tissue engineering to salvage and restore injured myocardium. The ICREC group is also involved in tissue engineering projects on biocompatible polymers to develop bioactive structures with biomedical applications.
Jelena Čelutkienė
Vilnius University,
Vilnius - Lithuania
Camille Gobeaux
Hopital Cochin
Paris - France
Professor Camille Chevenier-Gobeaux is affiliated with AP-HP and University of Paris. She has participated in the 3 previous editions of the BMF.
Alexandre Mebazaa
University of Paris,
Paris - France
Professor Alexandre Mebazaa is appointed by the University of Paris and is head of the anesthesia and critical care department of the Saint Louis-Lariboisière - Fernand Widal University Hospitals.
Since January 2019, he heads the MASCOT (Cardiovascular Markers in Stressed CONdiTions - UMR-S 942) research unit, which is funded by INSERM and the University of Paris.
His research interests include the mechanisms of contractile impairment during acute heart failure and worldwide studies on biomarkers in acute cardiac insufficiency. He was a member or Chairman of several study steering committees such as SURVIVE, COMPOSE, TRUE-HF, FROG-ICU, Natrium, Strong-HF.
Since 2020 he has been the FHU PROMICE coordinator (Hospital-University Federation) and co-director for the project “Precision medicine for the comprehensive care of seriously ill patients”), the objectives of which are to show that precise phenotyping of patients associated with biophysical models and big data improve decision-making systems in the perioperative period.
Janine Pöss
Herzzentrum Leipzig,
Leipzig - Germany
Jane-Lise Samuel
University of Paris,
Paris - France
Pr Jane-Lise Samuel (University of Paris 7, France) opened the symposium by providing an overview of sex differences in normal and pathological hearts. Indeed, lines of evidence indicate that cardiovascular sexual dimorphism exists in normal and diseased hearts—from the cellular level (cardiomyocyte, endothelial cell, vascular smooth muscle cells) to the organ. Dr Samuel also highlighted the sex-specific differences from the impact of ageing, cardiac hypertrophy, heart failure, and of exposure to ischaemic insult or chemotherapy.